Embryonic placenta development

pathway activity — cross-omics
GO:0001892Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Embryonic placenta development pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are KRT18, GGCX, and SEMA3F, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Embryonic placenta development activity versus KRT18 in BRCA (Pearson r = -0.20).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAKRT18 →+1.234+0.472<.001<.00135
BRCAGGCX →+0.358+0.537.001<.00134
BRCASEMA3F →+0.979+0.394<.001.00334
BRCAKRT8 →+1.097+0.394<.001<.00134
CCRCCKRT19 →+2.405+0.619<.001.00534
BRCADAG1 →+0.491+0.394<.001.00534
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0001892 vs KRT18 — BRCA

Per-sample scatter of Embryonic placenta development activity vs KRT18 in BRCA.

Explore this scatter interactively →

Exploration